###### Key messages

What is already known about this subject?
=========================================

-   Surveys of medical undergraduate rheumatic and musculoskeletal disease (RMD) curricula in individual European countries suggest variations in curriculum content.

-   A survey of undergraduate RMD curriculum in medical schools across Europe has not been performed.

What does this study add?
=========================

-   This survey highlights areas of similarities and differences in undergraduate curricula across Europe.

How might this impact on clinical practice?
===========================================

-   It is hoped that the results of this survey will catalyse the development and agreement of a minimum core European Curriculum for undergraduate medical education in RMDs.

Introduction {#s1}
============

The European League Against Rheumatism (EULAR) Standing Committee on Education and Training (ESCET) published guidelines for rheumatic and musculoskeletal diseases (RMDs) undergraduate core curriculum in 1999, and there have been other attempts to harmonise the curriculum of undergraduate teaching in RMDs.[@R1] Since then, some countries have developed curricula for RMDs, for example, France. However, surveys in individual European countries, the USA and the Asia-Pacific region demonstrated substantial variations in curriculum content.[@R3] The content of undergraduate curricula for RMDs in medical schools across Europe has not been compared. This is necessary to provide a framework for developing pan-European educational resources and to encourage harmonisation of curricula in RMDs. With this in mind, the objective of this study approved by the EULAR School of Rheumatology (ESoR) (Undergraduate Classroom) was to survey the undergraduate RMD curricula in European medical schools.

Methods {#s2}
=======

The undergraduate RMDs curriculum of University of Nottingham is based on the ESCET guidance[@R1] and was used to develop a questionnaire. The survey document elicited yes/no responses and included the option for providing additional detailed information. This was reviewed by ESoR (Undergraduate Classroom) to assess face validity and was emailed to members of the ESoR (Undergraduate Classroom) and ESCET, in January 2017, with reminder in 4 weeks.

Results {#s3}
=======

Twenty-one schools from 11 countries responded ([online supplementary table S1](#SF1){ref-type="supplementary-material"}). The questionnaires were completed by tenured faculty with teaching responsibilities and knowledge of their curriculum.
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All schools taught differentiation between inflammatory and mechanical joint pain, and to make observations about the musculoskeletal system ([online supplementary table S2](#SF1){ref-type="supplementary-material"}). The identification and characterisation of symptoms and signs of arthropathy at hand, wrist, elbow, gleno-humeral, hip, knee, ankle and foot joints was taught in \>90% of the responding institutions. In contrast, identification of periarticular lesions was taught in five institutions. However, students were expected to be aware of these conditions in majority of institutions ([online supplementary figure S1](#SF1){ref-type="supplementary-material"}). All institutions gave students opportunity to examine patients. Over 95% of the responding institutions taught the differential diagnosis of acute and chronic monarthritis, oligo-arthritis and inflammatory polyarthritis.

Investigations relevant to RMDs and general principles of management were included in most curricula ([table 1](#T1){ref-type="table"}, [online supplementary figure S2, table S3](#SF1){ref-type="supplementary-material"}). Common RMDs such as osteoarthritis, neck and low back pain, fibromyalgia and regional pain, bone diseases and crystal deposition diseases were included in majority of curricula with some variation in content ([online supplementary figures S3--5, table S4](#SF1){ref-type="supplementary-material"}). There was uniformity in coverage of autoimmune rheumatic diseases (AIRDs) in most curricula ([table 2](#T2){ref-type="table"}). While rare manifestations such as atlanto-axial subluxation in rheumatoid arthritis were included in 17 curricula, an exploration of long-term physical, psychological and social effects or the contribution of the multi-disciplinary team (MDT), and drug counselling and monitoring were only included in one curriculum. An outline of appropriate management plan for comorbidities was included in only two curricula.

###### 

Curriculum content for management of common and uncommon RMD conditions

  Condition                                    N (% schools)
  -------------------------------------------- ---------------
  Osteoarthritis                               20 (95.2%)
  Chronic back pain                            18 (85.7%)
  Nerve root entrapment                        19 (90.5%)
  Fibromyalgia                                 17 (81%)
  Osteoporosis including primary preventions   20 (95.2%)
  Gout including treatment to target           20 (95.2%)
  CPP deposition disease                       16 (76.2%)
  Apatite crystal deposition                   13 (61.9%)
  Rheumatoid arthritis                         20 (95.2%)
  Spondyloarthritis                            20 (95.2%)
  SLE                                          21 (100%)
  Anti-phospholipid syndrome                   19 (90.5%)
  Systemic sclerosis                           19 (90.5%)
  Sjögren's syndrome\*                         18 (85.7%)
  Polymyalgia rheumatica                       21 (100%)
  Giant cell arteritis                         19 (90.50%)
  Systemic vasculitis                          18 (85.7%)
  Inflammatory myopathies                      17 (81%)
  Bone/joint infection                         19 (90.5%)
  Osteomalacia                                 16 (76.2%)
  Osteonecrosis                                15 (71.4%)
  Paget's disease of bone                      15 (71.4%)

\*Either primary or secondary.

CPP, calcium pyrophosphate; RMD, rheumatic and musculoskeletal disease; SLE, systemic lupus erythematosus.

###### 

Curriculum content for autoimmune inflammatory rheumatic diseases

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                     RA   SpA spectrum   SLE (APS)   Systemic sclerosis   Sjögren's\   Inflammatory myopathies   Systemic vasculitis   Giant cell arteritis   Polymyalgia rheumatica
                                                                          syndrome                                                                            
  ------------------ ---- -------------- ----------- -------------------- ------------ ------------------------- --------------------- ---------------------- ------------------------
  Pathology          21   20             21          19                   19           --                        --                    19                     --

  Clinical feature   21   20             21 (20)     20                   19           18                        20                    19                     21

  Outcome            21   20             21          19                   19           --                        --                    19                     --

  Investigations     21   20             21 (20)     20                   20           17                        19                    19                     21
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

APS, anti-phospholipid syndrome; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; SpA, spondyloarthritis.

The risk factors, common causative organisms, signs and symptoms, differential diagnosis, and investigation of bone and joint infection were included in 19 curricula. Bony malignancy including metastases were included in fewer curricula ([online supplementary table S6](#SF1){ref-type="supplementary-material"}), while uncommon conditions were included in very few institutions ([online supplementary table S7](#SF1){ref-type="supplementary-material"}).

Discussion {#s4}
==========

This is the first survey of undergraduate RMDs curriculum of a number of medical schools across several European countries. It found areas of harmony and differences in curriculum content. There were similarities in teaching on AIRDs, while discrepancies were obvious on assessments such as gait examination, periarticular assessment and assessment for hypermobility. Similarly, identification of disability and role of MDT were taught in few institutions. Some medical schools included advanced imaging techniques with relevance to RMDs, while over 20% schools did not teach investigations undertaken on synovial fluid. While pharmacological management of autoimmune and other rheumatic diseases was included, there was a lack of teaching on adjunctive therapies and coping strategies. Factors underpinning variation in curriculum content may include different roles of rheumatologists across Europe and the need to tailor training to match local demands. The role of a rheumatologist depends on the number of rheumatologists per capita, postgraduate training and competing management of RMDs by other specialists such as orthopaedics, physiotherapists and general practitioners. Given the small number of medical schools that responded, we are unable to provide geographic comparisons.

Currently, a nationwide curriculum exists in France, but not in many other European countries to the best of our knowledge. It is hoped that the results of this survey will catalyse the development of a core European curriculum for undergraduate medical education in RMDs. The aim of undergraduate medical education has moved from acquisition of knowledge to acquiring competence, and this may make it easier to harmonise curricula across Europe once the expected competencies are standardised. Development of a core curriculum is likely to improve the amount of time devoted to teaching about RMDs. For instance, a recent survey of Canadian medical schools observed that an average of just 2.3% of their curriculum time was devoted to education about RMDs, despite these disorders being responsible for 13.7%--27.8% of all primary care consultations in Canada.[@R7] Additionally, it will also improve the coverage of musculoskeletal topics in undergraduate textbooks.[@R8]

Research suggests that even when a condition is included in the curriculum, the delivery of teaching may be variable, and recently qualified doctors may have substantial deficits in their knowledge base as exemplified in a study in which majority of recently qualified doctors did not demonstrate competence about long-term management of gout.[@R9]

There are several caveats to our findings. First, this is a small sample of European medical schools, so generalisability may be limited. Second, we have not collected data on the amount of teaching, the teaching methods used, the detail to which each topic is taught, specific learning objectives and the quantity of exposure to patients. We feel that these data would be difficult to collect reliably as medical schools have several associated hospitals where the delivery of teaching occurs, and this may vary from place to place.

In conclusion, this survey highlights areas of similarities and differences in undergraduate curricula across Europe. It is hoped that it will catalyse the development of a core European Curriculum for undergraduate education in RMDs.
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